D-1343-2016 Class II Terminated

Recalled by Pharmakon Pharmaceuticals, Inc. — Noblesville, IN

FDA drug recall D-1343-2016 was initiated by Pharmakon Pharmaceuticals, Inc. on April 20, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated January 11, 2018). Affected quantity: 70.

Recall Details

Product Type
Drugs
Report Date
July 20, 2016
Initiation Date
April 20, 2016
Termination Date
January 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
70

Product Description

Bupivacaine HCI 0.25% in 0.9% Sodium Chloride, 500 mL Intravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0994-03

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

Code Information

All Sterile Compounded Products within Expiry